Análisis de la cuota de mercado y oportunidades de la vacuna contra la Haemophilus influenzae tipo B (2025-2031)
Haemophilus Influenzae Type B Vaccine Market Report Analysis
Haemophilus Influenzae Type B Vaccine Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- GlaxoSmithKline plc
- Lanzhou Institute of Biological Products Co., Ltd.
- McKesson Corporation
- Medline Industries, Inc.
- Merck Sharp & Dohme Corp.
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Walvax Biotechnology Co., Ltd.
Regional Overview
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
- Medio Oriente y África
Market Segmentation
By Tipo
- vacuna HIB
- DTaP-IPV
By Formulación
- HIB monovalente líquido
- HIB combinado líquido
- HIB monovalente liofilizado
- HIB combinado liofilizado
By Aplicación
- hospitales
- laboratorios académicos y de investigación
- empresas farmacéuticas y biotecnológicas
- otros
By Geografía
- América del Norte
- Europa
- Asia-Pacífico
- América del Sur y Central
Get Free Sample For